The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•29 April 2026•

1 min read

Itron Faces Caution as Sales Decline and Book-to-Bill Ratio Weakens

Key Facts

1Itron's first-quarter sales declined 3% to $587 million with margins under pressure.

2The company recorded a weak book-to-bill ratio of 0.81x, indicating a slowdown in future sales growth.

3Recent acquisitions totaling $850 million are raising concerns regarding deal multiples and future earnings dilution.

Itron is facing increased scrutiny after reporting a 3% decline in first-quarter sales to $587 million, as profit margins remain under pressure. The company recorded a weak book-to-bill ratio of 0.81x, a metric that signals a potential slowdown in future revenue growth. Despite management's optimistic forward guidance, analysts remain cautious regarding the company's recent $850 million acquisition strategy. Concerns are mounting over the high deal multiples and the potential for future earnings dilution. Market experts suggest that muted organic growth and weak bookings data are offsetting the positive narrative provided by leadership, weighing on overall investor sentiment.